Suchergebnisse - "Anti-viral"

PubPharm (1.399)

21

Healthcare professionals' understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19

enthalten in: Expert review of anti-infective therapy | 2024

von Munir, M. | Khan, A. | Khan, T.

22

Drug repurposing of FDA-approved anti-viral drugs via computational screening against novel 6M03 SARS-COVID-19

enthalten in: Irish journal of medical science | 2024

von Waseem, W. | Zafar, R. | Jan, M. | +4

23

Mapping Extracellular Space Features of Viral Encephalitis to Evaluate the Proficiency of Anti-Viral Drugs

enthalten in: Advanced materials (Deerfield Beach, Fla.) | 2024

von Wang, L. | Chen, H. | Wang, Z. | +6

24

Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection

enthalten in: Frontiers in pharmacology | 2024

von Maen, A. | Gok Yavuz, B. | Mohamed, Y. | +12

25

AMMI Canada Practice Point : Updated recommendations for treatment of adults with symptomatic COVID-19 in 2023-2024

enthalten in: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada | 2024

von Grant, J. | Lam, J. | Goyal, S. | +11

26

COVID-19 vaccination produces exercise-responsive SARS-CoV-2 specific T-cells regardless of infection history

enthalten in: Journal of sport and health science | 2024

von Smith, K. | Zúñiga, T. | Baker, F. | +6

27

Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19

enthalten in: Med (New York, N.Y.) | 2024

von Mao, L. | Shaabani, N. | Zhang, X. | +38

ErratumIn: Med. 2024 Feb 9;5(2):169-171. - PMID 38340710

28

A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2024

von Dobson, R. | Holden, D. | Vickaryous, N. | +7

29

Impact of oseltamivir on the risk of cancer

enthalten in: Frontiers in oncology | 2024

von Chuang, P. | Tzang, B. | Tzang, C. | +3

30

Genome-wide and targeted CRISPR screens identify RNF213 as a mediator of interferon gamma-dependent pathogen restriction in human cells

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Matta, S. | Kohio, H. | Chandra, P. | +5